Modulight is a preclinical stage company developing precision treatments for severe neurological disorders characterized by pathological activity in the brain. They are pioneering a revolutionary optogenetic therapeutic platform that restores balance to the brain by precisely targeting pathological activity when and where it occurs.
No recent news for this company.